Association between oral JAK-1 inhibitors and infection risks in atopic dermatitis: a retrospective analysis of the FAERS database

BackgroundJanus kinase (JAK)-1 inhibitors have been approved for moderate-to-severe atopic dermatitis (AD). Despite favorable efficacy, their real-world infection risk profile requires further investigation.MethodsWe conducted a retrospective disproportionality analysis using the U.S. Food and Drug...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zenan Tang, Zhanglei Mu, Xiaojie Wang, Yan Zhao
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-11-01
Col·lecció:	Frontiers in Medicine
Matèries:	Janus kinase inhibitors atopic dermatitis adverse events FAERS database infection
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1694688/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!